Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-26 4:23 pm Purchase |
2024-12-18 | 13G | Gaxos.ai Inc. GXAI |
Mitchell P. Kopin | 292,897 4.990% |
292,897 (New Position) |
Filing History |
| 2024-11-13 11:20 am Purchase |
2024-09-30 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 45,205 4.990% |
45,205 (New Position) |
Filing History |
| 2024-11-13 11:19 am Purchase |
2024-09-30 | 13G | Nuvve Holding Corp. NVVE |
Mitchell P. Kopin | 34,281 4.990% |
34,281 (New Position) |
Filing History |
| 2024-11-13 11:19 am Sale |
2024-09-30 | 13G | PharmaCyte Biotech, Inc. PMCB |
Mitchell P. Kopin | 793,747 9.990% |
-109,665 (-12.14%) |
Filing History |
| 2024-11-13 11:18 am Purchase |
2024-09-30 | 13G | Innovative Eyewear, Inc. LUCY |
Mitchell P. Kopin | 126,073 4.990% |
126,073 (New Position) |
Filing History |
| 2024-11-13 11:18 am Sale |
2024-09-30 | 13G | PainReform Ltd. PRFX |
Mitchell P. Kopin | 26,202 4.500% |
-24,198 (-48.01%) |
Filing |
| 2024-11-13 11:18 am Unchanged |
2024-09-30 | 13G | NAYA Biosciences, Inc. NAYA |
Mitchell P. Kopin | 15,333 4.500% |
0 (Unchanged) |
Filing History |
| 2024-11-13 11:18 am Purchase |
2024-09-30 | 13G | Enveric Biosciences, Inc. ENVB |
Mitchell P. Kopin | 1,289 3.100% |
644 (+100.00%) |
Filing History |
| 2024-11-13 11:17 am Sale |
2024-09-30 | 13G | Tantech Holdings Ltd TANH |
Mitchell P. Kopin | 10,956 4.990% |
-9,423 (-46.24%) |
Filing History |
| 2024-11-13 11:16 am Purchase |
2024-09-30 | 13G | Tian Ruixiang Holdings Ltd TIRX |
Mitchell P. Kopin | 53,667 2.200% |
0 (+0.00%) |
Filing History |
| 2024-11-13 11:15 am Purchase |
2024-09-30 | 13G | Interactive Strength Inc. TRNR |
Mitchell P. Kopin | 808,179 4.500% |
808,179 (New Position) |
Filing History |
| 2024-11-13 11:15 am Purchase |
2024-09-30 | 13G | Bio-Path Holdings, Inc. BPTH |
Mitchell P. Kopin | 194,862 4.990% |
141,162 (+262.87%) |
Filing History |
| 2024-11-13 11:14 am Purchase |
2024-09-30 | 13G | Catheter Precision, Inc. VTAK |
Mitchell P. Kopin | 181,336 4.990% |
19,331 (+11.93%) |
Filing History |
| 2024-11-13 11:14 am Purchase |
2024-09-30 | 13G | Bone Biologics Corporation BBLG |
Mitchell P. Kopin | 110,122 4.990% |
10,517 (+10.56%) |
Filing History |
| 2024-11-13 11:14 am Purchase |
2024-09-30 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 20,182 4.990% |
13,991 (+226.00%) |
Filing History |
| 2024-11-13 11:13 am Sale |
2024-09-30 | 13G | Avinger, Inc. AVGR |
Mitchell P. Kopin | 152,118 4.990% |
-56,741 (-27.17%) |
Filing History |
| 2024-10-03 4:12 pm Purchase |
2024-09-26 | 13G | Theriva Biologics, Inc. TOVX |
Mitchell P. Kopin | 118,526 4.990% |
118,526 (New Position) |
Filing History |
| 2024-09-12 7:56 pm Purchase |
2024-09-03 | 13G | Catheter Precision, Inc. VTAK |
Mitchell P. Kopin | 162,005 9.500% |
162,005 (New Position) |
Filing History |
| 2024-09-06 7:45 pm Purchase |
2024-08-29 | 13G | BioCardia, Inc. BCDA |
Mitchell P. Kopin | 185,689 4.990% |
185,689 (New Position) |
Filing History |
| 2024-09-06 7:43 pm Purchase |
2024-08-29 | 13G | Richtech Robotics Inc. Class B Common Stock RR |
Mitchell P. Kopin | 2,585,275 4.990% |
2,585,275 (New Position) |
Filing History |